Patents by Inventor Rocio Lopez

Rocio Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230003739
    Abstract: The invention relates to an optical method for detecting at least one target molecule (TM) contained in a sample at a determined concentration, which comprises: (a) bringing a sample containing the TM into contact, in a liquid medium, with a solution containing nanoparticles (NPs), the surface of the NPs having been coated or functionalised with at least one type of specific bioreceptor (BR) of the target molecule to be detected (NP-BR), such that the BRs specifically recognise the TM, thus forming conjugates of the NP-BRs with the TMs (NP-BR-TMs); (b) separating the nanoparticles conjugates (NP-BR-TMs and/or NP-BRs) formed in the previous step; (c) bringing the nanoparticles conjugates (NP-BR-TMs and/or NP-BRs) into contact with a sensor surface of an optical transducer that operates by means of reflection and/or transmission, the response of which is based on optical interference, the sensor surface being functionalised by immobilising thereon: (i) the target molecule (TM) or (ii) at least one specific bior
    Type: Application
    Filed: November 25, 2020
    Publication date: January 5, 2023
    Applicants: UNIVERSIDAD POLITÉCNICA DE MADRID, BIO OPTICAL DETECTION, S.L.
    Inventors: Miguel HOLGADO BOLAÑOS, Araceli DÍAZ PERALES, María GARRIDO ARANDIA, Rocío LÓPEZ ESPINOSA, Alejandro ROMERO SAHAGÚN, María Fe LAGUNA HERAS, Luis FERNÁNDEZ PACIOS, Beatriz SANTAMARÍA FERNÁNDEZ, Yolanda RAMÍREZ ALONSO, Francisco Javier SANZA GUTIÉRREZ
  • Patent number: 8440648
    Abstract: The present invention provides for compositions, kits and methods for treatment of intraepithelial neoplasia, where the compositions include catecholic butanes, which include NDGA derivatives.
    Type: Grant
    Filed: July 19, 2005
    Date of Patent: May 14, 2013
    Assignees: Erimos Pharmaceuticals LLC, University of Maryland, Baltimore, Johns Hopkins University
    Inventors: Neil Frazer, Jonathan Heller, Rocio Lopez, Melissa Rhodes, Ru Chih C. Huang, Richard Dalby, Niharika Khanna
  • Publication number: 20080096967
    Abstract: The present invention provides for a composition, kit and method for treatment of diseases, where the composition contains at least one catecholic butane, including NDGA compounds and derivatives, together with a pharmaceutically acceptable carrier that may include solubilizing agents or excipients, where the composition is suitable for injection into animals.
    Type: Application
    Filed: January 27, 2006
    Publication date: April 24, 2008
    Applicant: ERIMOS PHARMACEUTICALS LLC
    Inventors: Rocio Lopez, Jessica Blomberg, Melissa Rhodes, Jonathan Heller
  • Publication number: 20080004346
    Abstract: The present invention provides for compositions, kits and methods for treatment of intraepithelial neoplasia, where the compositions include catecholic butanes, which include NDGA derivatives.
    Type: Application
    Filed: July 19, 2005
    Publication date: January 3, 2008
    Applicants: ERIMOS PHARMACEUTICALS LLC, JOHNS HOPKINS UNIVERSITY, UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Neil Frazer, Jonathan Heller, Rocio Lopez, Melissa Rhodes, Ru Chih Huang, Richard Dalby, Niharika Khanna